EACR 2024

10 - 13 June 2024 CEST
Rotterdam, Netherlands


Oxford Nanopore are sponsoring, exhibiting and presenting at this event. Please visit us at Booth #75 if you are able to attend the event.

The Oxford Nanopore sponsored industry symposium Accelerating precision oncology research with nanopore sequencing will take place on Tuesday 11th June in the Port Room at 08:30 - 09:15 hrs (CET).

Register below and join the session in good time to take your seat. Seats allocated on a first come first serve basis.

Symposium summary: Native, PCR-free nanopore sequencing, with unrestricted read lengths, offers a unique view into cancer biology. This allows the identification of single nucleotide variants, structural variants, and epigenetic modifications on a haplotype level — from a single dataset. In this session, we’ll explore how these technical benefits open up a new window of understanding into cancer genomes, featuring projects ranging from cancer whole-genome sequencing and targeted sequencing assays to cell-free DNA sequencing with methylation calling.


picture of Christophe Fleury

Welcome and introductions

Christophe Fleury, Oxford Nanopore Technologies


picture of Mathilde Filser

Exploring structural variants in cancer predisposition genes: the potential of nanopore adaptive sampling

Mathilde Filser, Curie Institute

I’m a 26 year-old resident in molecular biology, currently working at the Curie Institue in Paris in...

picture of Tomás Di Domenico

An (epi-)genomics analysis of drug resistance in Multiple Myeloma

Tomás Di Domenico, Spanish National Cancer Research Centre (CNIO)

I'm a computer scientist working on bioinformatics. My current focus is the study of drug resistance...